|Bid||161.30 x 1100|
|Ask||161.53 x 900|
|Day's Range||159.39 - 161.69|
|52 Week Range||123.57 - 164.13|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||134.48|
|Earnings Date||Feb. 11, 2020 - Feb. 16, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||178.59|
IQVIA™ (NYSE: IQV) today announced that AstraZeneca (LON: AZN) has selected IQVIA Technologies’ Orchestrated Customer Engagement (OCE) platform to further its digital agenda and establish its "Field of the Future."
Solid technological suite, growth opportunities from emerging markets and efforts to boost its presence in real-world business are the major positives for IQVIA Holdings (IQV).
VANCOUVER, Nov. 5, 2019 /CNW/ - Nextleaf Solutions Ltd. ("Nextleaf", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA), a cannabis extraction technology company that owns a portfolio of eight (8) issued patents pertaining to industrial-scale extraction and purification of cannabinoids, is pleased to provide the following corporate update. In 2019, the Company has been focused on developing intellectual property and building licensed capacity for large-scale extraction and distillation of THC and CBD.
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
IQVIA (IQV) delivered earnings and revenue surprises of 1.91% and 0.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.-- -- Third-quarter revenue $2,769 million Adjusted EBITDA $593 million GAAP Diluted Earnings per Share $0.29; Adjusted Diluted Earnings per Share $1.60 Technology and Analytics Solutions adds 20 new Orchestrated Customer Engagement wins during the third quarter R&D Solutions quarterly services net book-to-bill ratio 1.31x; next twelve months revenue from ...
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IQVIA Holdings Inc. , will announce its third-quarter 2019 financial results before the market opens on Wednesday, October 30, 2019. The IQVIA management team will also host a conference call and webcast at 9:00 a.m.
IQVIA™ (IQV) today announced the launch of Orchestrated Patient Engagement (OPE), a new cloud-based software as a service (SaaS) solution that helps close the gap between life sciences companies and patients. The OPE SaaS solution is powered by Belong.Life technology to allow life sciences customers to facilitate interactions and gain insights from patients who opt-in, assisting in the commercialization process.
IQVIA Consumer Health announces its unique global technology and analytics suite to support the self-care and wellness industry from product concept to consumer use
IQVIA's (IQV) latest launch is aimed at helping MedTech companies comply with the new European Union Medical Device Regulation, through extended capabilities.